How Glytec is advancing insulin management in the hospital

Growth and new partnerships have Glytec excited for the future of its Glucommander insulin dosing decision support software.

After years of running a hospitalist group and mentoring hospitals on quality improvement, blood clot prevention and more, Dr. Jordan Messler found himself falling into a lot of work on diabetes.

Messler cut his teeth on quality improvement around diabetes, observing that inpatient glycemia impacts about 40%-50% of patients in the hospital. That work brought him to Glytec, where he now serves as chief medical officer.

“The work that I’ve done in quality improvement around glycemic control has been to help to standardize care,” Messler told Drug Delivery Business News. “We know what best practices are to manage diabetes in the hospital and, largely, that revolves around insulin.”

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0

Glytec enters insulin management partnership with Nebraska Medicine

Glytec announced today that it entered into a strategic partnership with Nebraska Medicine to advance patient safety and innovation in insulin management.

Under the agreement, Nebraska Medicine will implement Glytec’s eGlycemic Management System (eGMS) across all 800 beds at its two hospitals, the Nebraska Medical Center and Bellevue Medical Center. The agreement will also see a collaboration on research and development initiatives to improve the safety and efficacy of insulin management in all hospital departments.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0

Glytec partners with Roche to enhance insulin dosing decision support software

Glytec announced today that it entered into a strategic partnership with Roche Diagnostics USA for a digital health collaboration.

Waltham, Massachusetts-based Glytec’s partnership combines its FDA-cleared Glucommander insulin dosing decision support software with Roche’s expertise in medical devices and IT solutions in an effort to address the challenges associated with inpatient blood sugar management at the hospital bedside.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0

Glytec garners cybersecurity certification for insulin management system

Glytec announced today that its eGlycemic Management System received certified status for information security from HITRUST.

Waltham, Massachusetts-based Glytec’s certification validates its platform’s ability to meet the highest standards for protecting sensitive data and information when working with its health system customers.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0

Glytec appoints first chief medical officer

Cloud-based insulin management software developer Glytec announced today that it appointed Dr. Jordan Messler as chief medical officer.

Messler’s responsibilities as the company’s first-ever CMO include spearheading continuous improvement initiatives for Glytec’s clinical strategy and product development.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0

Glytec names Nausheen Moulana as chief technology officer

Cloud-based insulin management software developer Glytec announced today that it appointed Nausheen Moulana as its chief technology officer.

In the role of CTO, Moulana will be responsible for Glytec’s product and technology vision, strategy and execution. She will lead the company’s product development teams with focus on enhancements in provider workflows, electronic health record (EHR) integrations, mobile apps and support for other diabetes technologies.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0

Glytec raises $21M for insulin dosing management tech

Glytec announced today that it raised $21 million in financing to fund its glycemic management technology.

Waltham, Mass.-based Glytec received $9 million in debt financing from Silicon Valley Bank, combined with $12 million in equity funding, led by Savitr with contribution from other private investors, according to a news release.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0

Glytec launches new insulin management system

Glytec announced today that it introduced the latest version of its eGlycemic Management System (eGMS) for managing insulin.

Waltham, Mass.-based Glytec’s eGMS is centered around the FDA-cleared Glucommander algorithm, which leverages real-time and historical data to recommend insulin dosing by learning each patient’s insulin sensitivity and anticipating future needs, leading to a personalized treatment regime that can reduce hypoglycemia, hyperglycemia, lengths of stay, readmissions and cost of care, according to a news release.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0